Recursion vs Cortex XSIAM

Side-by-side comparison to help you choose the best tool.

Recursion

paid
Data & Analytics
4.4 / 5.0

Recursion is a clinical-stage biotechnology company using AI to industrialise drug discovery. It combines large biological image datasets with ML to identify disease-biology relationships and predict therapeutic candidates. Recursion's platform has generated one of the largest proprietary biological datasets in existence, enabling AI-driven target identification and compound screening at new scale.

Best for: Pharmaceutical partners seeking AI drug discovery collaboration with one of the world's leading clinical-stage AI biotech companies
Visit Recursion

Cortex XSIAM

paid
Data & Analytics
4.7 / 5.0

Palo Alto Networks' AI-driven security operations platform that consolidates SIEM, SOAR, and endpoint detection into one AI SOC platform. XSIAM uses AI to automatically investigate and close up to 99% of alerts without analyst involvement, dramatically reducing mean time to respond. The platform integrates threat intelligence from Unit 42 and enforces consistent security policies across the environment.

Best for: Large enterprises looking to modernise their SOC with a unified AI-driven platform
Visit Cortex XSIAM
Feature Comparison
Feature Recursion Cortex XSIAM
Pricing paid paid
Category Data & Analytics Data & Analytics
Rating ★★★★☆ 4.4 ★★★★½ 4.7
Best For Pharmaceutical partners seeking AI drug discovery collaboration with one of the world's leading clinical-stage AI biotech companies Large enterprises looking to modernise their SOC with a unified AI-driven platform
Views 4 5
Pros & Cons — Recursion
Pros
  • Pioneer in AI-driven drug discovery at scale
  • Proprietary dataset is a competitive moat
  • Active clinical programmes validate the approach
Cons
  • Pharmaceutical industry-specific
  • Platform not publicly available
Pros & Cons — Cortex XSIAM
Pros
  • Dramatically reduces alert fatigue through AI automation
  • Single platform eliminates tool sprawl in SOC
  • Strong threat intelligence from Unit 42 research team
Cons
  • Premium enterprise pricing with complex licensing
  • Migration from existing SIEM can be resource-intensive
Key Features — Recursion
  • AI-powered target identification
  • Large-scale biological image analysis
  • ML compound screening
  • Disease-biology mapping
  • Partnership programs
Key Features — Cortex XSIAM
  • AI-driven alert triage and auto-closure
  • Unified SIEM, SOAR, and EDR platform
  • Unit 42 threat intelligence integration
  • Automated incident response workflows
  • Behavioural analytics and UEBA

We use cookies to improve your experience on AIOneFrame. Essential cookies are always active. By clicking "Accept All", you also agree to analytics and marketing cookies. Learn more